| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/08/2010 | WO2010038124A1 An improved process for preparing pyrimidine propenaldehyde |
| 04/08/2010 | WO2010038081A2 Heterocyclic derivatives and methods of use thereof |
| 04/08/2010 | WO2010038043A1 Pyrimide derivatives and their pharmaceutical use |
| 04/08/2010 | WO2010037688A1 Process for the synthesis of halogenated cyclic compounds |
| 04/08/2010 | WO2010037271A1 A group of amino substituted benzoyl derivatives and their preparation and their use |
| 04/08/2010 | US20100087641 Method and Materials for Quaternary Amine Catalyzed Bisulfite Conversion of Cytosine to Uracil |
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100087466 Novel small molecule dnak inhibitors |
| 04/08/2010 | US20100087461 Arylamide pyrimidone compounds |
| 04/08/2010 | US20100087460 Arylamide pyrimidone derivatives |
| 04/08/2010 | US20100087459 Forms of lapatinib compounds and processes for the preparation thereof |
| 04/08/2010 | US20100087453 Compounds, screens, and methods of treatment |
| 04/08/2010 | US20100087448 Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100086955 Small Molecule Inhibitors of Ghrelin O-Acyltransferase |
| 04/08/2010 | CA2739347A1 Uracil compounds and a herbicide comprising the same |
| 04/08/2010 | CA2738256A1 A group of amino substituted benzoyl derivatives and their preparation and their use |
| 04/08/2010 | CA2735921A1 Process for the synthesis of halogenated cyclic compounds |
| 04/07/2010 | EP2172470A1 Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex |
| 04/07/2010 | EP2172460A1 Compositions useful as inhibitors of JAK and other protein kinases |
| 04/07/2010 | EP2170844A1 Novel polymorphs of erlotinib hydrochloride and method of preparation |
| 04/07/2010 | EP2170843A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 04/07/2010 | EP2170842A1 Protein kinase inhibitors and methods for using thereof |
| 04/07/2010 | EP2170841A1 Process for introduction of hydroxyethoxy side chain in bosentan |
| 04/07/2010 | EP2170840A1 An improved process for preparing purine derivative |
| 04/07/2010 | EP2170839A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 04/07/2010 | EP2170838A1 Particulates of a crth2 antagonist |
| 04/07/2010 | EP2170837A2 Process for preparing 2-(3-{6-[2-(2,4-dichlorophenyl)-ethylamino]-2-methoxypyrimidin-4-yl)-phenyl)-2-methylpropionic acid |
| 04/07/2010 | EP2170830A1 Compounds and methods for kinase modulation, and indications therefor |
| 04/07/2010 | EP2170814A2 Antibacterial agents |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | EP1551829B1 Novel compounds with antibacterial activity |
| 04/07/2010 | EP1305296B9 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 04/06/2010 | US7692011 8-hydroxy and 8-mercapto quinazolinones |
| 04/06/2010 | US7692010 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia |
| 04/06/2010 | US7692009 Reference standard for characterization of rosuvastatin |
| 04/06/2010 | US7692008 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia |
| 04/06/2010 | US7692007 Process for the preparation of onium salts having a low chloride content |
| 04/06/2010 | US7691868 N-{8-[2-chloro-5-(3-methylamino-prop-1-ynyl)-phenyl]-4,5-dihydro-thiazolo[4,5-h]quinazolin-2-yl}-acetamide; PI3-kinase modulators for the treatment of inflammatory or allergic diseases |
| 04/06/2010 | US7691866 Anticancer agents |
| 04/06/2010 | US7691865 4-(2-pyridin-2-yl-pyrazolo[1,5-a]pyridin-3-yl)-pyrimidin-2-ylamine; 4-[2-(6-methyl-pyridin-2-yl)-pyrazolo[1,5-a]pyrimidin-3-yl]-pyrimidin-2-ylamine; high affinity for Alk 5 and/or Alk 4 hence useful as antagonists thereof; fibrotic disorders |
| 04/06/2010 | US7691864 Anti-hypertensive composition and methods of treatment |
| 04/06/2010 | US7691853 Pyrazole compounds useful as protein kinase inhibitors |
| 04/06/2010 | US7691635 Such as heat resistant diazomethyl compounds; kits for solid phase nucleic acid synthesis |
| 04/06/2010 | CA2464846C Dibenzylamine compounds and pharmaceutical use thereof |
| 04/06/2010 | CA2361057C Quinoline derivatives and quinazoline derivatives |
| 04/06/2010 | CA2351709C Novel triazolo(4,5-d)pyrimidine compounds |
| 04/01/2010 | WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 04/01/2010 | WO2010035284A2 An improved process for the preparation of rosuvastatin calcium |
| 04/01/2010 | WO2010034931A1 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof |
| 04/01/2010 | WO2010034153A1 New 2-pyrimidinyloxy (sulfo) benzoxy olefin acid ester compounds and uses thereof |
| 04/01/2010 | WO2010002845A3 Quinazoline derivatives |
| 04/01/2010 | WO2010001042A3 Cosmetic composition, compound, and cosmetic treatment method |
| 04/01/2010 | US20100081811 Method for the nitration of 4,6-dihydroxy-2-methylpyrimidine |
| 04/01/2010 | US20100081679 Diaminopyrimidines as fungicides |
| 04/01/2010 | US20100081677 Heteroarylamide pyrimidone derivatives |
| 04/01/2010 | US20100081675 Fused multicyclic compounds as protein kinase inhibitors |
| 04/01/2010 | US20100081673 Heteroaryl antagonists of prostaglandin d2 receptors |
| 04/01/2010 | US20100081665 Anti-Malarial Compounds |
| 04/01/2010 | CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 03/31/2010 | EP2168581A2 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
| 03/31/2010 | EP2167476A2 Novel hiv reverse transcriptase inhibitors |
| 03/31/2010 | EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
| 03/31/2010 | EP2167464A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) |
| 03/31/2010 | EP1786782B1 Bisaryl-sulfonamides |
| 03/31/2010 | CN101687822A Di(arylamino)aryl compound |
| 03/31/2010 | CN101687821A protein kinase inhibitors and methods for using thereof |
| 03/31/2010 | CN101687820A Method for producing quinazoline derivative |
| 03/31/2010 | CN101687819A Novel preparation for external use |
| 03/31/2010 | CN101687818A Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid |
| 03/31/2010 | CN101687817A Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
| 03/31/2010 | CN101687816A Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase |
| 03/31/2010 | CN101687801A Ethers of naphtalene carboxylic acid amides as cancer cure |
| 03/31/2010 | CN101687796A Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 03/31/2010 | CN101687790A Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) |
| 03/31/2010 | CN101684099A Propionic acid derivative of substituted aromatic ring and aromatic heterocycle and preparation method and application thereof |
| 03/31/2010 | CN101684098A 5-lipoxygenase inhibitor and preparation method, medical composite and application thereof |
| 03/31/2010 | CN101684097A Phenylpyrimidine amines as ige inhibitors |
| 03/30/2010 | US7687625 Antidiabetic agents; obesity; controlling appetite |
| 03/30/2010 | US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders; |
| 03/30/2010 | US7687511 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers |
| 03/30/2010 | US7687510 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 03/30/2010 | US7687508 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/30/2010 | US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders |
| 03/30/2010 | US7687501 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists |
| 03/30/2010 | US7687500 Substituted oxetanes, method of making, and method of use thereof |
| 03/30/2010 | US7687480 Phosphonate compounds |
| 03/30/2010 | US7687435 herbicides; act against broad-leaved weeds and grass weeds in crops such as wheat, rice, corn, soya and cotton without causing any significant damage to the crop plants |
| 03/30/2010 | US7687282 Detection of transmembrane potentials by optical methods |
| 03/25/2010 | WO2010033168A2 Amide compounds, compositions and uses thereof |
| 03/25/2010 | WO2010032261A1 Process for preparation of bosentan |
| 03/25/2010 | WO2010032009A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use |
| 03/25/2010 | US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 03/25/2010 | US20100076000 Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 03/25/2010 | US20100075990 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 03/25/2010 | US20100075988 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis |
| 03/25/2010 | US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators |
| 03/25/2010 | US20100075967 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 03/25/2010 | US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |